Other Events ·
At an extraordinary general meeting on July 6, 2026, shareholders approved a share capital reduction and reorganization
HAOHaoxi Health Technology Ltd
At an extraordinary general meeting on July 6, 2026, shareholders approved a share capital reduction and reorganization. The company's authorized share capital will be reduced from US$35.2 trillion to US$11 million by reducing the par value of Class A and Class B ordinary shares from US$0.32 to US$0.0000001 per share. The resulting credit from this reduction will be transferred to a distributable reserve account to be used at the board's discretion, including to offset accumulated losses. Shareholders also approved the adoption of the ninth amended and restated memorandum and articles of association to reflect these changes. Haoxi Health Technology operates in the healthcare technology industry.